December 30, 2020
Orexo announces new US patent for ZUBSOLV®
Media
December 28, 2020
Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS)
December 21, 2020
Oncopeptides enrolls the first patient in the phase 3 LIGHTHOUSE combination study in multiple myeloma
December 21, 2020
Positive results show that C21 can become an important complement to COVID-19 vaccines
December 17, 2020
BONESUPPORT moves to Mid Cap
December 17, 2020
Spruce Biosciences Added to Russell 2000®, 3000® and Microcap® Indexes
December 15, 2020
Vicore Pharma announces Last Patient Last Visit in the mechanistic phase II study with C21 in systemic sclerosis
December 10, 2020
Fusion Pharmaceuticals Initiates Multi-Dose Portion Of Phase 1 Trial Of FPI-1434 In Patients With Advanced Solid Tumors
December 10, 2020
GenSight Biologics Announces Publication of Results from LUMEVOQ® REVERSE Pivotal Phase III Trial and Non-Human Primate Study in Science Translational Medicine
December 09, 2020
Full data set of Oncopeptides phase 2 HORIZON study in multiple myeloma published in the Journal of Clinical Oncology